10-1074 - National Institute of Allergy and Infectious Diseases, Rockefeller University, Gilead
3BNC117 - Rockefeller University, Cornell University, Frontier Biotech, Gilead
lefitolimod (MGN1703) - OncXerna Therap, iPharma, Gilead
THE IMPACT OF 3BNC117; 10-1074; AND LEFITOLIMOD ON HIV-1 PERSISTENCE: THE TITAN TRIAL (CROI 2023) - Feb 13, 2023 - Abstract #136; Pres time: Feb 21, 2023; 10:13 AM - 10:21 AM; Location: Ballroom 1 (Level 5); No abstract available 
Human Immunodeficiency Virus • Infectious Disease
https://www.croiconference.org/wp-content/uploads/sites/2/resources/2023/croi2023-program-guide-v5.pdf
 
Jesper D. Gunst; Dag Henrik Reikvam; James H. McMahon; Marie H. Pahus; Jesper F. Højen; Isik S. Johansen; Henrik Nielsen; Thomas Lars Benfield; Jan Gerstoft; Sharon Lewin; Martin Tolstrup; Thomas A. Rasmussen; Marina Caskey; Michel C. Nussenzweig; Ole S. Søgaar
 
Feb 13, 2023
 
Prev Next